| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
90.04(M) |
| Last
Volume: |
19,513,858 |
Avg
Vol: |
3,164,533 |
| 52
Week Range: |
$0.1356 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Caracciolo Anthony |
Executive Chairman |
• • – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,093,972 |
2,093,972 |
|
- |
|
| Caracciolo Anthony |
Executive Chairman |
• • – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
I/I |
200,000 |
200,000 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2017-04-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
737,368 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2017-04-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,243,170 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2016-10-21 |
4 |
B |
$0.66 |
$9,930 |
I/I |
15,000 |
15,750 |
2.58 |
- |
|
| Mulholland Michael D |
CFO, Treasurer and Secretary |
• – – |
2016-10-17 |
4 |
B |
$0.66 |
$7,238 |
D/D |
11,000 |
37,043 |
2.74 |
- |
|
| Naydenov Jordan G |
Director |
– • – |
2016-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
5,097,242 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2016-03-07 |
5 |
GD |
$0.00 |
$0 |
I/I |
375,000 |
750 |
|
- |
|
| Alpha Venture Capital Partners, L.p. |
Indirect |
– – • |
2015-06-24 |
4 |
OE |
$0.68 |
$3,535,627 |
I/I |
5,237,966 |
7,474,509 |
|
- |
|
| Dockery Carl |
Director |
– • • |
2015-06-24 |
4 |
OE |
$0.68 |
$3,535,627 |
I/I |
5,237,966 |
7,474,509 |
|
- |
|
| Alpha Venture Capital Partners, L.p. |
Indirect |
– – • |
2015-06-05 |
4 |
B |
$0.50 |
$18,345 |
I/I |
36,690 |
2,236,543 |
1.5 |
- |
|
| Dockery Carl |
Director |
– • • |
2015-06-05 |
4 |
B |
$0.50 |
$18,345 |
I/I |
36,690 |
2,236,543 |
2.17 |
- |
|
| Alpha Venture Capital Partners, L.p. |
Indirect |
– – • |
2015-05-05 |
4 |
B |
$0.50 |
$52,077 |
I/I |
104,153 |
2,199,853 |
1.5 |
- |
|
| Dockery Carl |
Director |
– • • |
2015-05-05 |
4 |
B |
$0.50 |
$52,077 |
I/I |
104,153 |
2,199,853 |
2.25 |
- |
|
| Alpha Venture Capital Partners, L.p. |
10% Owner |
– – • |
2015-02-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,095,700 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2014-11-14 |
4 |
OE |
$0.55 |
$1,733,333 |
D/D |
2,666,666 |
4,097,242 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2014-10-30 |
4 |
B |
$0.72 |
$18,720 |
I/I |
26,000 |
88,136 |
2.1 |
- |
|
| Mulholland Michael D |
CFO, Treasurer and Secretary |
• – – |
2014-10-15 |
4 |
B |
$0.79 |
$1,975 |
D/D |
2,500 |
26,043 |
2.66 |
- |
|
| Dockery Carl |
Director |
– • – |
2014-09-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,095,700 |
|
- |
|
169 Records found
|
|
Page 7 of 7 |
|
|
0.07 (29.82%) 
